These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18566039)

  • 21. An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes.
    Berry LM; Zhao Z
    Drug Metab Lett; 2008 Jan; 2(1):51-9. PubMed ID: 19356071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions.
    Fang ZZ; Zhang YY; Ge GB; Liang SC; Sun DX; Zhu LL; Dong PP; Cao YF; Yang L
    Phytother Res; 2011 Feb; 25(2):256-63. PubMed ID: 20641061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
    He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
    Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.
    Derks M; Fowler S; Kuhlmann O
    Curr Med Res Opin; 2009 Apr; 25(4):891-902. PubMed ID: 19245299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity.
    Kimura Y; Ito H; Ohnishi R; Hatano T
    Food Chem Toxicol; 2010 Jan; 48(1):429-35. PubMed ID: 19883715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
    Korzekwa KR; Krishnamachary N; Shou M; Ogai A; Parise RA; Rettie AE; Gonzalez FJ; Tracy TS
    Biochemistry; 1998 Mar; 37(12):4137-47. PubMed ID: 9521735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.
    Hijazi Y; Boulieu R
    Drug Metab Dispos; 2002 Jul; 30(7):853-8. PubMed ID: 12065445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
    Wang X; Cheung CM; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of olomoucine II with human liver microsomal cytochromes P450.
    Siller M; Anzenbacher P; Anzenbacherova E; Dolezal K; Popa I; Strnad M
    Drug Metab Dispos; 2009 Jun; 37(6):1198-202. PubMed ID: 19251823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside.
    Sun DX; Lu JC; Fang ZZ; Zhang YY; Cao YF; Mao YX; Zhu LL; Yin J; Yang L
    Phytother Res; 2010 Nov; 24(11):1670-5. PubMed ID: 21031626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silybin is metabolized by cytochrome P450 2C8 in vitro.
    Jancová P; Anzenbacherová E; Papousková B; Lemr K; Luzná P; Veinlichová A; Anzenbacher P; Simánek V
    Drug Metab Dispos; 2007 Nov; 35(11):2035-9. PubMed ID: 17670841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.
    Huang Z; Guengerich FP; Kaminsky LS
    Carcinogenesis; 1998 May; 19(5):867-72. PubMed ID: 9635876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
    Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
    J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles.
    Kumar V; Wahlstrom JL; Rock DA; Warren CJ; Gorman LA; Tracy TS
    Drug Metab Dispos; 2006 Dec; 34(12):1966-75. PubMed ID: 16963489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminus.
    Subramanian M; Tam H; Zheng H; Tracy TS
    Drug Metab Dispos; 2010 Jun; 38(6):1003-9. PubMed ID: 20215413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia.
    Niemira M; Dastych J; Mazerska Z
    Biochem Pharmacol; 2013 Jul; 86(2):231-41. PubMed ID: 23688499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.